DE
49
3
NEE
39
9
IPG
43
3
RRC
52
2
CNX
67
4
TXN
29
4
CRM
65
6
GS
65
16
AIV
39
6
MTB
38
4
HSIC
42
2
WMB
58
3
UHS
50
4
BAC
38
3
ILMN
31
4
AMP
43
2
SPG
45
2
AMT
30
2
XYL
29
4
UAL
73
3
DE
49
3
NEE
39
9
IPG
43
3
RRC
52
2
CNX
67
4
TXN
29
4
CRM
65
6
GS
65
16
AIV
39
6
MTB
38
4
HSIC
42
2
WMB
58
3
UHS
50
4
BAC
38
3
ILMN
31
4
AMP
43
2
SPG
45
2
AMT
30
2
XYL
29
4
UAL
73
3
Financhill
Back

Mereo BioPharma Group PLC 10K Form

Sell
37

MREO
Mereo BioPharma Group PLC

Last Price:
$3.34
Seasonality Move:
18.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MREO News And Ratings

See the #1 stock for the next 7 days that we like better than MREO

MREO Financial Statistics

Sales & Book Value

Annual Sales: $10M
Cash Flow: $-7.5M
Price / Cash Flow: 0
Annual Sales: $0.47
Price / Book: 7.14

Profitability

EPS (TTM): -0.30000
Net Income (TTM): $-45.3M
Gross Margin: $7.4M
Return on Equity: 0%
Return on Assets: 0%

Mereo BioPharma Group PLC Earnings Forecast

Key Mereo BioPharma Group PLC Financial Ratios

  • The Gross Profit Margin over the past 7 years for MREO is 74.26%.
  • The Selling, General & Administrative Expenses for MREO have been equal to 184.24% of Gross Profit Margin.
  • The Research & Development expenses have been 174.18% of Revenue.
  • The Interest Expense is -9.78% of Operating Income.
  • The Net Earning history of MREO is -294.66% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Mereo BioPharma Group PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MREO
CUSIP: 589492
Website: mereobiopharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MREO Technical Analysis vs Fundamental Analysis

Sell
37
Mereo BioPharma Group PLC (MREO) is a Sell

Is Mereo BioPharma Group PLC a Buy or a Sell?